COVID-19: WHO chief scientist says India exhibited capacity to innovate, manufacture vaccines

By: |
March 2, 2021 3:37 PM

India has shown the capacity to be a global-scale manufacturer and also an innovator when it comes to coronavirus vaccines, World Health Organization's Chief Scientist Soumya Swaminathan said Monday.

Covid-19 VaccineThe stories of development of vaccines are amazing examples of how time can be compressed and scientific mobilisation can be initiated.

India has shown the capacity to be a global-scale manufacturer and also an innovator when it comes to coronavirus vaccines, World Health Organization’s Chief Scientist Soumya Swaminathan said Monday. Speaking at the Global Bio-India 2021, she opined that the fight against the coronavirus pandemic is at a very critical junction now as cases have suddenly gone up, particularly in Europe and America. There are many uncertainties now, especially on the different variants of the virus, she noted.

“India has shown the capacity to be a manufacturer at the global scale and also be an innovator when it came to vaccine development. There is a huge amount of scope to study the impact of vaccines, which needs to be thought through by a very coordinated approach,” she said. As many as 30 vaccines are at different stages of development in India. Covaxin, developed indigenously by Biotech, and Covishield, developed by Oxford-AstraZeneca and being manufactured at Serum Institute of India, are already in use in the country.

The vaccine candidates of Zydus Cadila and Russia’s Sputnik V are in phase 3 of the human clinical trials. Sputnik V, which is being manufactured by Reddy’s Laboratories in India, has initiated the process for Emergency Use Authorisation (EUA) with the Drugs Controller General of India (DCGI). India has supplied vaccines to several nations while many others have also placed orders for the same. Vinod Paul, Member (Health), NITI Aayog lauded the efforts of scientific community and said the speed with which the solutions during the pandemic appeared was phenomenal.

The stories of development of vaccines are amazing examples of how time can be compressed and scientific mobilisation can be initiated. The intent to have a global footprint in the manufacturing sector when it came to COVID-19 vaccine was path-breaking and something to be proud of. We have realised that we have the potential to deliver in a speedy manner, like we did for vaccine distribution, he said. The three-day Global Bio-India 2021 was inaugurated Monday by Harsh Vardhan, the minister of Science & Technology, and Health & Family Welfare.

Get live Stock Prices from BSE, NSE, US Market and latest NAV, portfolio of Mutual Funds, Check out latest IPO News, Best Performing IPOs, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Financial Express is now on Telegram. Click here to join our channel and stay updated with the latest Biz news and updates.

Next Stories
1Convert some govt, private hospitals into dedicated COVID-19 facilities: Delhi CM Arvind Kejriwal tells officials
2COVID-19: States ignore WHO recommendation on Ivermectin, here’s what doctor who wrote white paper on the drug has to say
3Non-adherence to COVID-19 norms, virulent strains could be behind surge in infections: AIIMS chief Dr Randeep Guleria